90359792
Dec 4, 2020
Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for Parkinson's Disease; Pharmaceutical products for the treatment of joint disease
PharmaceuticalsPharmaceutical products development; Pharmaceutical research and development; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Computer and Scientific